Founded in 2009, Strōma Medical Corporation is a late-stage research and development company located in Laguna Beach, CA. Inventor/scientist Gregg Homer, JSD (PhD) developed and patented a non-invasive procedure to change eye color from brown to blue. It is our intent that the procedure will be performed in the doctor's office with only a topical anesthetic and will take less than 20 seconds to complete. The permanent eye color change will occur gradually over the following two to four weeks and our clinical studies are designed to confirm these results. The procedure is suitable for people of all races and nationalities.
The procedure is currently in clinical trials and not commercially available anywhere in the world. The release date is not yet known, but we encourage you to register with us for periodic updates, including our development progress, clinical trial dates and territories, projected commercial release dates and territories, and other up-to-the-minute information through Strōma Updates.
Strōma's mission is to design, develop and distribute a state-of-the art system providing physicians and patients with a safe and effective method for permanent eye color change.
Strōma Senior Management* and Board of DirectorsDouglas J. Daniels*CEO & Director, Strōma Medical CorporationManaging Director, Prospectives LLC; CEO, HydroCision; CEO, Vein Rx; Vice President, Syntheon Corporation; Vice President & General Manager, MicroVasive Endoscopy; Vice President, New Market Development, Boston Scientific Corp.
Gregg Homer, JSD (PhD)*Chairman & Chief Scientific Officer, Strōma Medical CorporationChairman and CEO, HomerLabs, LLC; Inventor, Strōma Technology; Partner, Entertainment Law Group, Inc.; Arbitrator, Screen Actors Guild; Adjunct Professor, Stanford Law School; Doctorate (Evolutionary Biology and Behavioral Game Theory), Stanford University; Law Degree, Stanford Law School; Senior Editor, Stanford Law Review; Master's Program, Stanford Graduate School of Economics; Master's Program (Creative Writing), Immaculate Heart College; Bachelor's Degree (English), Immaculate Heart College; Member, American Academy of Ophthalmology
J. Andy CorleyDirector, Strōma Medical CorporationFounder, YELROC Consulting, Inc.; Senior Consultant and Former President, Bausch & Lomb Surgical; Co-Founder, eyeonics, Inc.; Co-Founder and Former General Manager (Refractive Surgery Division), Chiron Ophthalmics; Chairman, Technolas Perfect Vision; Executive Chairman, NeoVista, Inc.; Venture Partner, One Focus Ventures
Edward PetersonDirector, Strōma Medical CorporationPresident & CEO, Acufocus, Inc.; Director, AqueSys, Inc.; Member, AAO Corporate Advisory Committee; Former Vice President of New Business Development, The Innovation Factory; Former Executive with Cooper Vision and Alcon Inc.; Veteran, USMC
Strōma Medical Advisory BoardIke Ahmed, MD, FRCSCAssistant Professor of Medicine, Glaucoma & Anterior Segment Surgery Fellowship Director, Research Fellowship Director, University of Toronto, Department of Ophthalmology and Vision Sciences, Credit Valley EyeCare, Mississauga, Ontario, Canada; Clinical Assistant Professor, University of Utah, Salt Lake City
Perry Binder, MS, MDClinical Professor, unsalaried, Gavin Herbert Eye Institute, University of California, Irvine
David Huang, MD, PhDDirector, Center for Ophthalmic Optics and Lasers, Casey Eye Institute, Portland, OR; Weeks Professor of Ophthalmic Research, Professor of Ophthalmic & Biomedical Engineering, Oregon Health & Science University, Portland, OR
Marguerite McDonald, MD, FACSClinical Professor of Ophthalmology, NYU School of Medicine, New York, NY; Adjunct Clinical Professor of Ophthalmology, Tulane University Health Sciences Center, New Orleans, LA; Ophthalmic Consultants of Long Island, Lynbrook, NY
J. Stuart Nelson, MD, PhDMedical Director, Beckman Laser Institute and Medical Clinic, Professor of Surgery, Dermatology and Biomedical Engineering, University of California, Irvine
Stephen Slade, MD, FACSCo-Founder, Slade & Baker Vision Center, Houston, Texas